Keyphrases
Adverse Outcomes
7%
Alternative Complement Pathway
15%
Alternative Pathway
7%
Anti-factor D
100%
Aortic Cross-clamping
7%
Baboon
15%
Blood Samples
7%
Cardiopulmonary Bypass
100%
Complement Activation
100%
Core Cooling
7%
Creatine Kinase
15%
Creatine kinase-MB (CK-MB)
23%
Flow Cytometry
7%
Human Factors
7%
Hypothermic Cardiopulmonary Bypass
7%
Inflammation Injury
7%
Interleukin-6
15%
Leukocyte Recruitment
100%
Monoclonal Antibody
100%
Monocyte Activation
7%
Monocytes
7%
Multiple Injections
7%
Murine Antibody
7%
Neutrophil Activation
7%
Neutrophils
7%
Normothermic Cardiopulmonary Bypass
7%
Novel Antibodies
7%
Rectal Temperature
7%
Rewarming
7%
Saline Solution
7%
Systemic Inflammation
23%
Tissue Injury
23%
Treatment Group
23%
Immunology and Microbiology
Alternative Complement Pathway
33%
Aortic Clamping
16%
Blood Plasma
33%
Complement Activation
100%
Complement Component C4d
16%
ELISA
16%
Factor D
100%
Interleukin 6
33%
Leukocyte Activation
100%
Monoclonal Antibody
100%
Monocyte
33%
Neutrophil
16%
Neutrophil Granulocyte
16%
Rectal Temperature
16%
Solution and Solubility
16%
Systemic Inflammation
50%
Warming
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
16%
Complement Component C3a
33%
Complement Component C4d
16%
Creatine Kinase
16%
Creatine Kinase Isoenzyme
16%
Creatine Kinase MB
50%
Enzyme-Linked Immunosorbent Assay
16%
Flow Cytometry
16%
Inflammation
50%
Interleukin 6
33%
Isoenzyme
33%
Lactate Dehydrogenase
33%
Monoclonal Antibody
100%
Sodium Chloride
16%
Tissue Injury
50%